Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Legrand

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Revue Medicale De Liege|August 30, 2007
[New therapeutic guidelines in cardiology]V Legrand, P Lancellotti, A Waleffe, et al.
Revue Medicale De Liege|February 25, 2000
[Image of the month. Percutaneous closure of an interauricular communications]M Massin, V Legrand, P Materne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1983
Evaluation of right-ventricular function by gated blood-pool scintigraphyV Legrand, M Chevigne, J Foulon, et al.
Revue Medicale De Liege|March 15, 1986
[Correction of congenital pulmonary stenosis by percutaneous transluminal valvuloplasty]V Legrand, P Materne, P Collignon, et al.
Acta Cardiologica|July 21, 2000
Stenting of the left main coronary artery. Local experience in LiègeA Ghavami, J Boland, V Legrand, et al.
Revue Medicale De Liege|September 26, 2009
[Elevation of cardiac biomarkers after strenuous physical exertion]C Dugauquier, M Hanssen, O Gach, et al.
Catheterization and Cardiovascular Diagnosis|January 1, 1996
Variability in estimation of coronary dimensions from 6F and 8F cathetersV Legrand, B Raskinet, C Martinez, et al.
The American Journal of Cardiology|February 1, 1983
Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart diseaseV Legrand, M Vandormael, P Collignon, et al.
Revue Medicale De Liege|July 1, 1980
[Current problems with implantable cardiac pacemakers]V Legrand, J C Demoulin, J Fourny, et al.
Gene Therapy|April 9, 2002
Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant virusesZ Raykov, V Legrand, H E Homann, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Revue Medicale De Liege|August 30, 2007
[New therapeutic guidelines in cardiology]V Legrand, P Lancellotti, A Waleffe, et al.
Revue Medicale De Liege|February 25, 2000
[Image of the month. Percutaneous closure of an interauricular communications]M Massin, V Legrand, P Materne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1983
Evaluation of right-ventricular function by gated blood-pool scintigraphyV Legrand, M Chevigne, J Foulon, et al.
Revue Medicale De Liege|March 15, 1986
[Correction of congenital pulmonary stenosis by percutaneous transluminal valvuloplasty]V Legrand, P Materne, P Collignon, et al.
Acta Cardiologica|July 21, 2000
Stenting of the left main coronary artery. Local experience in LiègeA Ghavami, J Boland, V Legrand, et al.
Revue Medicale De Liege|September 26, 2009
[Elevation of cardiac biomarkers after strenuous physical exertion]C Dugauquier, M Hanssen, O Gach, et al.
Catheterization and Cardiovascular Diagnosis|January 1, 1996
Variability in estimation of coronary dimensions from 6F and 8F cathetersV Legrand, B Raskinet, C Martinez, et al.
The American Journal of Cardiology|February 1, 1983
Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart diseaseV Legrand, M Vandormael, P Collignon, et al.
Revue Medicale De Liege|July 1, 1980
[Current problems with implantable cardiac pacemakers]V Legrand, J C Demoulin, J Fourny, et al.
Gene Therapy|April 9, 2002
Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant virusesZ Raykov, V Legrand, H E Homann, et al.
Pageof 15